Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-29 @ 9:43 PM
Study NCT ID:
NCT05734495
Status:
RECRUITING
Last Update Posted:
2025-05-11
First Post:
2023-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-01-25
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-06
First Submit QC Date:
None
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-07
Last Update Post Date:
2025-05-11
Last Update Post Date Type:
ACTUAL